Drug absorption and hepatic drug metabolism in patients with different types of intestinal shunt operation for obesity. A study with phenazone.

Seventeen patients with intestinal shunt for obesity and 11 control patients were given 15 mg phenazone per kg perorally to estimate the rate of absorption and hepatic metabolism of phenazone. The rate of absorption and the plasma clearance of phenazone as well as the 4-hydroxyphenazone excretion in the urine did not differ in the patients with intestinal shunt after the weight had stabilized. Thus, drug absorption and hepatic drug metabolizing capacity appear to be unaffected 12--57 months after intestinal shunting.

[1]  G. Greisen,et al.  Two compartment analysis of plasma elimination of phenazone in normals and in patients with cirrhosis of the liver. , 2009, Acta pharmacologica et toxicologica.

[2]  E. Vesell,et al.  Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration , 1974, Clinical pharmacology and therapeutics.

[3]  J. Gazet,et al.  Treatment of Gross Obesity by Jejunal Bypass , 1974, British medical journal.

[4]  C. Christiansen,et al.  Calcium absorption and bone mineral contents following intestinal shunt operation in obesity. , 1974, Scandinavian journal of gastroenterology.

[5]  L. Ranek,et al.  Clearance of Antipyrine‐Dependence of Quantitative Liver Function , 1974, European journal of clinical investigation.

[6]  D. Azarnoff,et al.  Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man. , 1974, Biochemical pharmacology.

[7]  L. Prescott,et al.  Rapid gas‐liquid chromatographic estimation of antipyrine in plasma , 1973, The Journal of pharmacy and pharmacology.

[8]  B. Brodie,et al.  Absorption of drugs from the stomach. II. The human. , 1957, The Journal of pharmacology and experimental therapeutics.

[9]  B. Brodie,et al.  The estimation of antipyrine in biological materials. , 1949, The Journal of biological chemistry.

[10]  M. Petri,et al.  Liver morphology and liver function before and after intestinal shunt operation for obesity. , 1975, Scandinavian journal of gastroenterology.

[11]  S. Moberg,et al.  Gastric emptying in healthy subjects and in patients with various malabsorptive states. , 1974, Scandinavian journal of gastroenterology.

[12]  F. Quaade,et al.  Vitamin B12 depletion in obese patients treated with jejunoileal shunt. , 1974, Scandinavian journal of gastroenterology.

[13]  K. Lenz,et al.  Change of bile acid metabolism and absorption of vitamin B 12 after intestinal shunt operation in obesity. A comparison of three types of operation. , 1974, Scandinavian journal of gastroenterology.

[14]  M. Gleeson,et al.  Cell turnover following small bowel resection and by-pass. , 1973, Digestion.

[15]  S. Jarnum,et al.  Intestinal shunt-operation in obesity. A comparison of three types of operation. , 1973, Scandinavian journal of gastroenterology.

[16]  B. Brodie,et al.  The fate of antipyrine in man. , 1950, The Journal of pharmacology and experimental therapeutics.